Cargando…
Auriculotemporal Carcinoma - A Retrospective Case Series
RATIONALE: Eleven cases with auriculotemporal cancer were reviewed for prognostic analysis. PATIENT CONCERNS: Follow-up ranged from 1.2 to 12 years (median 5.01 years). DIAGNOSIS, TREATMENT AND OUTCOME: Three patients with parotid gland carcinoma, out of those, two had chemoradiotherapy, died in the...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976850/ https://www.ncbi.nlm.nih.gov/pubmed/36874770 http://dx.doi.org/10.4103/ams.ams_17_22 |
Sumario: | RATIONALE: Eleven cases with auriculotemporal cancer were reviewed for prognostic analysis. PATIENT CONCERNS: Follow-up ranged from 1.2 to 12 years (median 5.01 years). DIAGNOSIS, TREATMENT AND OUTCOME: Three patients with parotid gland carcinoma, out of those, two had chemoradiotherapy, died in the first 2 years of treatment. They were at stage T4 and tumour progressed with distant metastasis. Otorrhoea was the most common symptom in patients with primary temporal bone carcinoma. One patient with auricular carcinoma had a recurrence at the primary site 13 months after surgery. One patient with T1, two patients with T2 and one patient with T3 have completed a 5-year survival period. One patient with T1 and another one with T2 are still at a 2-year follow-up period with no recurrence. TAKE-AWAY LESSONS: Complete resection is the treatment of choice. Post-operative radiotherapy is highly recommended. The most decisive prognostic indicator is the advanced stage. Early diagnosis has great importance. |
---|